H KARL RADKE
Allopathic & Osteopathic Physicians|Family Medicine CASPER, WY NPI 1720188972
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine WY Medtronic, Inc. All categories
General Payments — all program years on this page
$716.25
- Category: General Payments
- Program years: PY2018–2024
- Record count: 31
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $153.17 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $153.17 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $36.17 | 1 |
| Acerta Pharma LLC | $32.08 | 2 |
| Novo Nordisk AS | $23.42 | 1 |
| ABBVIE INC. | $17.36 | 1 |
| Amgen Inc. | $15.37 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $15.10 | 1 |
| Merck Sharp & Dohme Corporation | $13.67 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1092654969 | Boston Scientific Corporation | $15.10 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096602609 | Novo Nordisk Inc | $23.42 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104531202 | AstraZeneca Pharmaceuticals LP | $13.50 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105346681 | ABBVIE INC. | $17.36 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105718022 | AstraZeneca Pharmaceuticals LP | $18.58 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117359472 | Amgen Inc. | $15.37 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119452517 | Medtronic, Inc. | $36.17 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141962614 | Merck Sharp & Dohme LLC | $13.67 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.